Compare
Johnson & Johnson vs Lilly (Eli) (JNJ vs LLY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Lilly (Eli) (LLY) +46.2%; so far this year the figures are +33.5% and +26.0%.
Lilly (Eli) is the larger company by market value, about 1.9 times the size of Johnson & Johnson.
On trailing earnings, JNJ trades at 41.9 times and LLY at 43.9 times.
Revenue grew +7.8% at JNJ and +45.5% at LLY over the last year.
JNJ yields 1.91%. LLY yields 0.49%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | LLY | |
|---|---|---|
| Price | $276.22 | $1,354.00 |
| 1-day | +1.43% | -0.79% |
| YTD | +33.47% | +25.99% |
| 1 year | +48.51% | +46.25% |
| 3 years | +85.77% | +144.20% |
| Market cap | $665.0B | $1.27T |
| P/E | 41.9 | 43.9 |
| P/S | 6.69 | 14.73 |
| P/B | 8.16 | 31.63 |
| Revenue growth | +7.80% | +45.50% |
| EPS growth | -36.40% | +50.70% |
| Gross margin % | 67.6 | 83.6 |
| Net margin % | 16.2 | 31.9 |
| ROE % | 19.7 | 68.5 |
| Debt / equity | 0.55 | 1.23 |
| FCF yield % | 3.1 | 2.4 |
| Dividend yield % | 1.91 | 0.49 |
| Beta | -0.09 | 0.29 |
| RSI (14) | 59.4 | 61.1 |
| Technical rating |